Breaking News Instant updates and real-time market news.

FOXA

21st Century Fox

$26.11

-0.66 (-2.47%)

, FOX

21st Century Fox

$25.48

-0.67 (-2.56%)

16:15
10/11/17
10/11
16:15
10/11/17
16:15

On The Fly: Top stock stories for Wednesday

Stocks drifted throughout most of the session as investors continue to count down until the start of the third quarter earnings season. Although a few major banks will report over the next couple of days, the reporting will begin in earnest next week. The averages built some upward momentum after the Fed released the minutes from last month's FOMC meeting and following a report that claimed Treasury Secretary Steven Mnuchin is "strongly pushing" for President Trump to pick current Federal Reserve governor Jerome Powell as the next chair of the central bank. ECONOMIC EVENTS: In the U.S., the JOLTS report showed job opening declined 58,000 to 6.08M in August. In Fed news, the FOMC meeting minutes showed that "many" committee members saw another rate hike was warranted, while a smaller number thought action could wait. In addition, several believed that further tightening should hinge on incoming data, though it was acknowledged that Hurricanes Harvey, Irma, and Maria would impact economic activity. COMPANY NEWS: Shares of Kroger (KR) gained 1% after the company announced in conjunction with its investor day meeting that it will explore strategic alternatives for its convenience store business, including a potential sale. Kroger also backed its FY17 adjusted earnings view and said that it is "striving for" EPS to be flat to slightly higher in FY18... Delta (DAL) shares rose about 1% after the airline operator reported revenue and profit that was better than expected for the third quarter despite challenges that included multiple hurricanes and the Mexican earthquake... Meanwhile, shares of 21st Century Fox (FOXA) dipped 2.5% after the U.S. Men's National Soccer Team failed to qualify for the 2018 World Cup. Fox Sports had agreed to pay $400M to secure English-broadcast rights to the 2018 and 2022 World Cup, but the broadcasts are expected to be less valuable after the loss. Though the company stated that it remains committed to airing the World Cup games, Bloomberg reported that the sports subsidiary estimates lower ad sales as a result of the U.S. team's absence... In other media news, President Donald Trump tweeted earlier, "With all of the Fake News Coming out of NBC and the Networks, at what point is it appropriate to challenge their License? Bad for country!" Following the tweet, National Association of Broadcasters CEO Gordon Smith said that it is "contrary" to the First Amendment to threaten TV license renewals. The owners of the "big 4" broadcast networks are Comcast (CMCSA), Disney (DIS), CBS (CBS) and 21st Century Fox. MAJOR MOVERS: Among the noteworthy gainers was Pretium Resources (PVG), which jumped 25% and was upgraded to Outperform at Scotiabank following the company's third quarter production update. Also higher was Aerie Pharmaceuticals (AERI), which gained 16% after the FDA posted briefing documents ahead of a meeting to discuss the company's Rhopressa treatment for open-angle glaucoma or ocular hypertension. Among the notable losers was Barracuda Networks (CUDA), which fell 12% after reporting quarterly results and providing guidance for the third quarter. Also lower was MannKind (MNKD), which dropped 18.5% after announcing agreements to sell 10.17M shares at $6.00 per share in a registered direct offering. INDEXES: The Dow rose 42.21, or 0.18%, to 22,872.89, the Nasdaq gained 16.30, or 0.25%, to 6,603.55, and the S&P 500 advanced 4.60, or 0.18%, to 2,555.24.

FOXA

21st Century Fox

$26.11

-0.66 (-2.47%)

FOX

21st Century Fox

$25.48

-0.67 (-2.56%)

CMCSA

Comcast

$37.42

-0.27 (-0.72%)

CMCSK

Comcast

DIS

Disney

$98.52

-1.06 (-1.06%)

CBS

CBS

$57.11

-0.28 (-0.49%)

KR

Kroger

$20.78

0.25 (1.22%)

DAL

Delta Air Lines

$53.07

0.37 (0.70%)

PVG

Pretium Resources

$12.11

2.43 (25.10%)

AERI

Aerie Pharmaceuticals

$64.30

8.95 (16.17%)

CUDA

Barracuda

$22.65

-3.0908 (-12.01%)

MNKD

MannKind

$5.47

-1.24 (-18.48%)

  • 11

    Oct

  • 11

    Oct

  • 11

    Oct

  • 12

    Oct

  • 13

    Oct

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 08

    Nov

  • 09

    Nov

  • 30

    Nov

  • 28

    Feb

FOXA 21st Century Fox
$26.11

-0.66 (-2.47%)

10/06/17
STFL
10/06/17
NO CHANGE
Target $200
STFL
Buy
Netflix 'still the best value' for consumers despite price hike, says Stifel
After Netflix (NFLX) disclosed it is raising subscription prices for the Standard and Premium tiers in the U.S., Stifel analyst Scott Devitt said he expects "similar round number increases" in a number of other markets, noting that the company has also confirmed increases for its top two U.K. plans. The analyst, who noted that Hulu's ad-free option and HBO Now (TWX) remain as expensive or more expensive than Netflix, said its streaming service is "still the best value on the consumer Internet." Devitt keeps a Buy rating and $200 price target on Netflix shares.
09/19/17
09/19/17
NO CHANGE

Cowen lowers price targets on media companies
Cowen analyst Doug Crentz cut his price targets for several media companies, as he believes that the margin pressure on TV networks will continue. The analyst believes that consensus estimates for TV broadcasters are too high, as he expects that the decline in the sector's EBITDA margin will more than double this year, driven by lower ad and affiliate revenue. He believes that two "deep-pocketed, low margin competitors -Netflix (NFLX) and Amazon (AMZN) - are the root of the problem. He cut his price target on Viacom (VIAB) to $31 from $41, on Discovery (DISCA) to $19 from $25, on Fox (FOXA) to $29 from $32, on CBS (CBS) to $69 from $70 and on Disney (DIS) to $94 from $95.
09/05/17
WELS
09/05/17
UPGRADE
Target $116
WELS
Outperform
Disney upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Marci Ryvicker upgraded Disney (DIS) to Outperform and raised her price target for the shares to $116 from $109. The owner of ESPN and ABC closed Friday up 31c to $101.50. Concerns over potential dilution from the BAMTech stake and the streaming apps are "widely overdone," Ryvicker tells investors in a research note where she also downgraded Viacom (VIAB). She expects the TV ecosystem will soon undergo on an accelerated push into over-the-top. As such, investors may need to start increasing exposure to media companies with solid streaming strategies, such as CBS (CBS), 21st Century Fox (FOXA), and Disney, and lessen exposure to those that do not, such as Viacom and Scripps Networks (SNI)/Discovery Communications (DISCA), Ryvicker argues. The analyst likes the current entry point for Disney shares.
08/11/17
PIPR
08/11/17
INITIATION
Target $35
PIPR
Overweight
21st Century Fox initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Stan Meyers started 21st Century Fox with an Overweight rating and $35 price target. Fox has some of the best mix of content and remains undervalued relative to peers, the analyst contends.
FOX 21st Century Fox
$25.48

-0.67 (-2.56%)

08/01/17
FBCO
08/01/17
NO CHANGE
Target $37
FBCO
Outperform
21st Century Fox, Sky deal to take longer to clear, says Credit Suisse
Credit Suisse analyst Omar Sheikh continues to believe the Sky (SKYAY) transaction will eventually receive full regulatory approval, but highlights there is an elevated risk to the deal if it is referred to the CMA, and at best an extended period before it gets cleared. Meanwhile, he believes the 2018 21st Century Fox (FOXA) organic equity story looks compelling, and reiterates an Outperform rating and $37 price target on the shares.
08/08/17
BNCH
08/08/17
NO CHANGE
BNCH
Buy
Fox-ION 'rumors' most likely a negotiating tactic, says Benchmark
Benchmark analyst Daniel Kurnos highlighted a "slew" of "inconsistencies" that make him skeptical of last week's "unsubstantiated rumor published by Bloomberg" regarding Fox (FOXA) potentially forming a JV with ION and pulling all of its affiliate agreements from Sinclair (SBGI), concluding in a note to investors that this was "just another negotiating tactic by the network." Fox's "cozy" agreements with Tribune (TRCO) may get disrupted by Sinclair's acquisition, added Kurnos, who has a Buy rating on Sinclair shares.
07/25/17
OTRG
07/25/17
DOWNGRADE
OTRG
Mixed
21st Century Fox downgraded to Mixed from Positive at OTR Global
OTR Global downgraded 21st Century Fox to Mixed from Positive
CMCSA Comcast
$37.42

-0.27 (-0.72%)

09/12/17
09/12/17
UPGRADE

Buy
Comcast upgraded to Buy on valuation at MoffettNathanson
As previously reported, MoffettNathanson upgraded Comcast to Buy from Neutral with a $45 price target. Analyst Craig Moffett said Comcast shares cheap following management comments on Q3 subscriber loses and the resulting stock selloff is overdone.
09/29/17
JPMS
09/29/17
NO CHANGE
JPMS
Expert sees positive settlements for TiVo, says JPMorgan
JP Morgan analyst Sterling Auty hosted Bloomberg Intelligence Litigation Analyst Matt Larson to discuss TiVo's (TIVO) ITC and District Court cases with Comcast (CMCSA, CMCSK) and Hulu. Larson said he believes settlement is the most likely outcome in both cases, which Auty sees as a positive for TiVo. A positive resolution could have "material upside" for TiVo's shares, as it bolsters the case for TiVo driving earnings to the $3 per share level, Auty added. JP Morgan kept an Overweight rating and $34 price target on TiVo shares.
09/12/17
09/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comerica (CMA) upgraded to Overweight from Neutral at Piper Jaffray with analyst Brett Rabatin saying the bank's mid-quarter update is better than expected. 2. Alcoa (AA) upgraded to Buy from Hold at Deutsche Bank with analyst Jorge Beristain basing the upgrade on the firm's commodity team raising its 2018 aluminum price forecast by 12% to $2,072 per ton. 3. Kroger (KR) upgraded to Buy from Hold at Pivotal Research with analyst Ajay Jain saying continued weakness in investor sentiment following Kroger's latest results presents a near-term buying opportunity. 4. Comcast (CMCSA) upgraded to Buy from Neutral at MoffettNathanson with analyst Craig Moffett saying Comcast shares cheap following management comments on third quarter subscriber loses and the resulting stock selloff is overdone. 5. Inovalon (INOV) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Ricky Goldwasser saying that the company's presentation at the firm's healthcare conference provided a line of sight to organic earnings acceleration in the second half of the year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CMCSK Comcast

04/24/17
OPCO
04/24/17
NO CHANGE
OPCO
Sprint, DISH the only assets for sale, says Oppenheimer
Oppenheimer analyst Timothy Horan noted that wireless companies will be allowed to discuss M&A, and says he sees Sprint (S) and possibly DISH (DISH) as the only assets for sale. The analyst believes the most likely outcome is for consolidation around the four major wireless providers, something along the lines of Charter (CHTR)/Sprint, T-Mobile (TMUS)/Comcast (CMCSA; CMCSK), Verizon (VZ)/DISH, with AT&T's (T) position "fairly solidified" with DirectTV/Time Warner (TWX). Further, Horan suspects Sprint will be sold first, most likely to Charter, although T-Mobile is a possibility and could be the controlling company/management and likely paying a premium for Sprint.
04/26/17
FBCO
04/26/17
NO CHANGE
Target $37
FBCO
Outperform
Hulu stake could be for sale this year, says Credit Suisse
Credit Suisse analyst Omar Sheikh notes that Comcast (CMCSA; CMCSK) will be free to sell its 30% stake in Hulu from the end of 2017. The analyst believes there is a $100B domestic revenue opportunity for targeted TV advertising long-term, which vertically integrated networks/distributors will be in a strong position to exploit. Therefore, Sheikh argues that it would make sense for 21st Century Fox (FOX; FOXA) to acquire Comcast's stake in Hulu, if it becomes available, subject to valuation and appropriate programming supply agreements. He reiterates an Outperform rating and $37 price target on 21st Century Fox's shares.
DIS Disney
$98.52

-1.06 (-1.06%)

10/09/17
10/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Outperform from Market Perform at Wells Fargo with analyst Larry Biegelsen saying J&J is poised to reaccelerate its sales growth due to accretion from the Actelion acquisition, a "more measured" than expected impact from biosimilar competition, "solid performance" of key drugs and a pipeline that is "coming to fruition." 2. Morgan Stanley (MS) upgraded to Outperform from Neutral at Credit Suisse with analyst Susan Roth Katzke citing the over 10% total return potential in the shares. 3. Disney (DIS) upgraded to Top Pick from Outperform at RBC Capital with analyst Steven Cahall saying he thinks the company has reached a turning point with ESPN approaching less than 20% of earnings and "non-Media" Disney remaining a global leader in content that is executing well. 4. INC Research (INCR) upgraded to Buy from Hold at Jefferies analyst David Windley saying the recent share pullback provides a "compelling" entry point. 5. British American Tobacco (BTI) upgraded to Buy from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/17
10/09/17
UPGRADE
Target $125

Top Pick
Disney upgraded to Top Pick on improved visibility at RBC Capital
As previously reported, RBC Capital upgraded Disney to Top Pick from Outperform, with analyst Steven Cahall saying he thinks the company has reached a turning point with ESPN approaching less than 20% of earnings and "non-Media" Disney remaining a global leader in content that is executing well. At a time when investors are worried about ad and affiliate trends, Disney is "the least media stock in the media sector" and its non-Media earnings and direct-to-consumer approach give the stock potential for a rerating, Cahall tells investors. The analyst, who trimmed his FY18 and FY19 earnings estimates for Disney, lowered his price target on the stock to $125 from $130.
10/09/17
RBCM
10/09/17
UPGRADE
RBCM
Top Pick
Disney upgraded to Top Pick from Outperform at RBC Capital
CBS CBS
$57.11

-0.28 (-0.49%)

09/13/17
NEED
09/13/17
NO CHANGE
NEED
CBS Internet video channels could be worth $7.2B, says Needham
Needham analyst Laura Martin estimates that CBS' (CBS) Internet video services could generate $1.2B of revenue in 2020. She notes that Netflix's (NFLX) market cap is six times its revenue. If CBS' Internet video services are valued using that multiple, they would be worth $7.2B, or 30% of CBS' current market cap, according to the analyst. She keeps an $80 price target and a Buy rating on the shares.
09/15/17
JPMS
09/15/17
NO CHANGE
Target $75
JPMS
Overweight
CBS recent share weakness overdone, says JPMorgan
JPMorgan analyst Alexia Quadrani views the recent pullback in shares of CBS (CBS) as overdone. The stock has underperformed over the prior month, down 12% versus the S&P 500 Index up 1%, Quadrani tells investors in a research note titled "Weather Channel's Gain is NFL's Pain; CBS Weakness Overdone." The analyst attributes yesterday's selloff to NFL ratings for week one, which declined 12% year-over-year. It is unreasonable to draw conclusions from just one weekend of games, especially last weekend given the storms, the analyst argues. Further, Quadrani says CBS CEO Les Moonves' comment yesterday that Amazon (AMZN) would be interested in bidding for NFL rights when they come due early next decade is "hardly news." She keeps an Overweight rating on CBS with a $75 price target.
KR Kroger
$20.78

0.25 (1.22%)

09/12/17
PIVT
09/12/17
UPGRADE
PIVT
Buy
Kroger upgraded to Buy from Hold at Pivotal Research
Pivotal Research analyst Ajay Jain upgraded Kroger to Buy with an unchanged price target of $25. The supermarket owner closed yesterday up 28c to $21.34. Continued weakness in investor sentiment following Kroger's latest results presents a near-term buying opportunity, Jain tells investors in a research note. The analyst, while admitting it is difficult to call an absolutely bottom amid an increasingly competitive operating environment, says the stock's risk/reward is "finally improving."
09/19/17
PIPR
09/19/17
DOWNGRADE
Target $72
PIPR
Neutral
Kellogg downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Michael Lavery downgraded Kellogg (K) to Neutral saying cereal could be at risk from shrinking center store space. Recent comments by Kroger (KR) and Campbell Soup (CPB) indicate retailer pushback is a real threat to packaged food suppliers, Lavery tells investors in a research note. He adds that scanner data suggests Kellogg's sales trends are worse than expected in both snacks and cereal. The analyst dropped his price target for Kellogg to $72 from $78.
10/04/17
BERN
10/04/17
NO CHANGE
BERN
Ahold Delhaize, Kroger deal would make sense, says Bernstein
Bernstein analyst Bruno Monteyne notes that Bloomberg is reporting speculation on Twitter (TWTR) that Ahold Delhaize (ADRNY) has hired advisors to study a possible $32/share Kroger (KR) bid. The analyst believes a merger makes sense both strategically and financially, but deal structure seems off - merger of equals rather than bid - and timing a bit too fast.
DAL Delta Air Lines
$53.07

0.37 (0.70%)

10/06/17
DBAB
10/06/17
DOWNGRADE
Target $38
DBAB
Hold
Spirit Airlines downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Michael Linenberg downgraded Spirit Airlines (SAVE) to Hold and lowered his price target for the shares to $38 from $42. The company's revenue outlook "may face greater downside risk" than peers given the competitive intensity of its markets, Linenberg tells investors in a research note previewing September quarter earnings for Airlines. His favorite names in the sector are Delta Air Lines (DAL), American Airlines (AAL) and Southwest (LUV).
10/03/17
JPMS
10/03/17
NO CHANGE
JPMS
Delta Air Lines estimates lowered on Hurricane Irma impact, says JPMorgan
JPMorgan analyst Jamie Baker lowered his Q3 EPS estimate for Delta Air Lines (DAL) to $1.52 from $1.60 after the company lowered its Q3 operating margin guidance, given the impact of Hurricane Irma. Despite the downward revision, Baker maintained an Overweight rating and $63 price target on Delta shares. Baker also noted that American Airlines (AAL) was likely to guide down as well, as American has a higher percentage of capacity traveling through Florida than Delta, 15.7% to 12.7%, respectively.
09/27/17
JPMS
09/27/17
NO CHANGE
Target $63
JPMS
Overweight
Delta price target lowered to $63 on revised profit sharing plan at JPMorgan
JPMorgan analyst Jamie Baker noted that Delta will harmonize its two existing profit sharing agreements to follow the higher, more expensive plan as of October 1, which prompted him to raise his estimated 2018 profit share expense by $416M to $1.3B and his 2019 expense estimate by $377M to about $1.5B. He lowered his price target on Delta to $63 from $67 to account for the higher expense estimates, but said the news does not change his thesis and he keeps an Overweight rating on the stock.
09/27/17
STFL
09/27/17
NO CHANGE
STFL
Big 4 airlines' exposure to Spirit lower than thought, says Stifel
Stifel analyst Joseph DeNardi believes that sell side analysts at other firms may be overstating the degree of overlap that the "Big 4" airlines - American Airlines (AAL), Delta (DAL), Southwest (LUV) and United Continental (UAL) - have with Spirit (SAVE) by not accurately adjusting to include only routes operated within the same time period as competitors. Adjusting to within a 2 hour time channel, he estimates only 5% of United's and Delta's total ASMs are directly exposed to Spirit, while 8% of American's ASMs and 11% of Southwest's are exposed, he tells investors. If United is hoping to influence Spirit's growth, it may choose to continue to compete aggressively, but if its goal is to improve margins, he would expect pricing to stabilize, DeNardi tells investors.
PVG Pretium Resources
$12.11

2.43 (25.10%)

10/11/17
SCOT
10/11/17
UPGRADE
SCOT
Outperform
Pretium Resources upgraded to Outperform from Sector Perform at Scotiabank
Scotiabank upgraded Pretium Resources to Outperform citing the positive Q3 production update.
10/11/17
ROTH
10/11/17
NO CHANGE
Target $17
ROTH
Buy
Roth Capital raises Pretium price target to $17 after production report
After Pretium Resources announced production results from its Brucejack Mine that were "well above expectations" for the mine's first full quarter, Roth Capital analyst Joe Reagor raised his price target on the stock to $17 from $16. The analyst, who sees this update underscoring that Brucejack is a world class mine and that Pretium is "significantly undervalued," keeps a Buy rating on the stock.
03/20/17
FBCO
03/20/17
INITIATION
Target $13.5
FBCO
Outperform
Pretium Resources initiated with an Outperform at Credit Suisse
Credit Suisse analyst Robert Reynolds started Pretium Resources with an Outperform rating and $13.50 price target.
03/08/17
RBCM
03/08/17
UPGRADE
RBCM
Outperform
Pretium Resources upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst Dan Rollins upgraded Pretium Resources to Outperform with a price target of C$18.
AERI Aerie Pharmaceuticals
$64.30

8.95 (16.17%)

10/02/17
MZHO
10/02/17
NO CHANGE
Target $70
MZHO
Buy
Aerie recent weakness a buying opportunity, says Mizuho
Mizuho analyst Difei Yang noted that Aerie Pharmaceuticals shares have fallen by about 20% since the company announced on September 20 that the FDA will hold an advisory committee meeting to discuss Rhopressa. However, after speaking with Aerie's management, the analyst believes a fair amount of preparation had already taken place prior to receiving the FDA notice and views the pullback in the stock as a buying opportunity. Yang keeps a $70 price target and Buy rating on Aerie shares.
10/05/17
COWN
10/05/17
NO CHANGE
Target $100
COWN
Outperform
Aerie Pharmaceuticals should receive positive FDA review next week, says Cowen
Cowen analyst Tyler Van Buren conducted an ophthalmology panel and survey and received very optimistic responses suggesting Rhopressa should receive a positive advisory committee vote on October 13, which should ultimately lead to approval. The panelists he spoke to believed the company's Rocket clinical trial program demonstrated that Rhopressa is an effective agent as it achieved non-inferiority to timolol, said Van Buren, who reiterated his Outperform rating and $100 price target on Aerie Pharmaceuticals shares.
10/11/17
JMPS
10/11/17
NO CHANGE
Target $68
JMPS
Outperform
Rhopressa meeting briefing document 'bullish' for Aerie, says JMP Securities
JMP Securities analyst Donald Ellis called the briefing document for the advisory meeting to review Aerie Pharmaceuticals' Rhopressa "bullish," noting that the document included a statement that the company has shown in three Phase 3 trials that the drug is non-inferior to timolol. "Surprisingly," the FDA included a sample product label, which it rarely does, suggesting the agency "is fully planning on approving Rhopressa," Ellis tells investors. He maintains an Outperform rating and $68 price target on Aerie shares, which are up 16% to $64.20 in afternoon trading.
10/11/17
MZHO
10/11/17
NO CHANGE
MZHO
Buy
FDA stance looks favorable towards Aerie's Rhopressa, says Mizuho
Mizuho analyst Difei Yang said the briefing documents for the FDA's advisory committee meeting to discuss Rhopressa make it appear that the agency's stance is favorable towards Aerie's treatment. The analyst views the FDA's modifications to Aerie's proposed language to be "very minor" and is encouraged by the language used in the indication and usage section. Yang keeps a Buy rating on Aerie Pharmaceuticals shares, which are trading higher following the posting of the meeting documents.
CUDA Barracuda
$22.65

-3.0908 (-12.01%)

10/11/17
KEYB
10/11/17
NO CHANGE
Target $30
KEYB
Overweight
KeyBanc remains a buyer of Barracuda after quarterly results
KeyBanc analyst Rob Owens notes that Barracuda's margin degradation is likely to carry the conversation, despite strong outperformance in billings and revenue. The analyst continues to like the underlying fundamentals in the story, and anticipates margins will expand in the second half of the year, after an investment-heavy first half. Owens remains a buyer, and reiterates an Overweight and $30 price target on the shares.
10/11/17
JPMS
10/11/17
NO CHANGE
Target $35
JPMS
Overweight
Barracuda post-earnings selloff a buying opportunity, says JPMorgan
JPMorgan analyst Sterling Auty attributes the post-earnings selloff in shares of Barracuda Networks to a lack of margin upside combined with no increase in annual guidance. Growth in the cloud business "continues to be impressive" with billings growth in excess of 22% this quarter, but like last quarter, the margin performance remains muted, Auty tells investors in a research note titled "2Q18: Opportunity Knocks Again." He sees the selloff as an opportunity, saying the "margin issue is the easier item to fix" and that upside in billings and revenue should carry more weight. The analyst keeps an Overweight rating on Barracuda with a $35 price target.
07/20/17
BTIG
07/20/17
NO CHANGE
Target $30
BTIG
Buy
Barracuda set-up favorable for Q2 upside, says BTIG
BTIG analyst Joel Fishbein Jr. said he believes Barracuda Networks is set-up favorably for upside both in Q2 and for the full year with its gross margins set to improve and its Public cloud success and new products providing potential upside to renewal rates. He reiterates his Buy rating and $30 price target on Barracuda shares.
10/11/17
JMPS
10/11/17
NO CHANGE
JMPS
Outperform
Barracuda results bode 'particularly well' for Proofpoint, says JMP Securities
JMP Securities analyst Erik Suppiger keeps his Market Perform rating on Barracuda Networks (CUDA) after the company reported generally in line Q2 results but guided Q3 slightly below consensus, saying he feels the stock is fairly valued given the company's transition to cloud-based products. He also noted that Barracuda highlighted robust momentum for cloud email security, which he views as something that bodes "particularly well" for Proofpoint (PFPT).
MNKD MannKind
$5.47

-1.24 (-18.48%)

10/02/17
MAXM
10/02/17
NO CHANGE
MAXM
MannKind still well-positioned to grow, says Maxim
Maxim analyst Jason Kolbert does not expect MannKind to declare bankruptcy because he does not believe that the company's main debtholders want to see that outcome, and because he thinks that its debt "can be managed." He says that over the longer term, revenue from the company's Afrezza product can enable it to overcome its debt. Kolbert keeps a $4 price target and a Buy rating on the shares.,
10/10/17
HCWC
10/10/17
INITIATION
Target $7
HCWC
Buy
MannKind initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat started MannKind with a Buy rating and $7 price target. The shares closed yesterday up 30c to $5.33. The "game-changing" new label approved last week will allow Afrezza to gain a footing in the "very large insulin space and become the significant product that its innovation merits," Livnat tells investors in a research note. The analyst expects MannKind, under new management, to soon recapitalize and eventually accelerate Afrezza growth to peak sales more than $725M in the U.S.
10/09/17
MAXM
10/09/17
NO CHANGE
Target $7
MAXM
Buy
MannKind price target raised to $7 from $4 at Maxim
Maxim analyst Jason Kolbert believes the FDA approval of a label revision for Afrezza translates into lower risk for the relaunch of the drug. Given the lower view of the risk, Kolbert raised his price target on MannKind shares to $7 from $4 and keeps a Buy rating on the stock.
10/03/17
MAXM
10/03/17
NO CHANGE
MAXM
Label revision should drive MannKind sales, says Maxim
Maxim analyst Jason Kolbert says that the new label on MannKind's Afrezza drug, which includes information about its speed of delivery, "should help drive adoption" of the drug, He keeps a $4 price target and a Buy rating on the shares.

TODAY'S FREE FLY STORIES

MERC

Mercer

$13.50

-0.05 (-0.37%)

20:51
10/18/17
10/18
20:51
10/18/17
20:51
Upgrade
Mercer rating change at RBC Capital »

Mercer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ADBE

Adobe

$153.00

2.62 (1.74%)

20:50
10/18/17
10/18
20:50
10/18/17
20:50
Upgrade
Adobe rating change at Pivotal Research »

Adobe upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 06

    Nov

MDB

MongoDB

20:46
10/18/17
10/18
20:46
10/18/17
20:46
Syndicate
MongoDB 8M share IPO priced at $24.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

VZ

Verizon

$48.65

0.25 (0.52%)

, PM

Philip Morris

$112.51

-0.14 (-0.12%)

20:25
10/18/17
10/18
20:25
10/18/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

VZ

Verizon

$48.65

0.25 (0.52%)

PM

Philip Morris

$112.51

-0.14 (-0.12%)

DHR

Danaher

$86.05

0.79 (0.93%)

BK

BNY Mellon

$54.46

0.5 (0.93%)

BX

Blackstone

$33.49

0.27 (0.81%)

BBT

BB&T

$46.54

0.02 (0.04%)

TRV

Travelers

$130.02

1.37 (1.06%)

PPG

PPG

$112.88

-0.08 (-0.07%)

RCI

Rogers Communications

$53.75

-0.23 (-0.43%)

NUE

Nucor

$57.28

0.17 (0.30%)

DOV

Dover

$93.57

-0.48 (-0.51%)

GPC

Genuine Parts

$98.04

1.18 (1.22%)

TXT

Textron

$53.57

0.5 (0.94%)

DGX

Quest Diagnostics

$92.05

-0.13 (-0.14%)

ADS

Alliance Data

$228.38

1.44 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 16

    Nov

  • 29

    Nov

  • 30

    Nov

  • 14

    Dec

HPE

HP Enterprise

$14.70

0.09 (0.62%)

19:12
10/18/17
10/18
19:12
10/18/17
19:12
Hot Stocks
HP Enterprise raises share buyback by $5B, raises regular dividend 15% »

Given HPE's strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

HPE

HP Enterprise

$14.70

0.09 (0.62%)

19:11
10/18/17
10/18
19:11
10/18/17
19:11
Hot Stocks
HPE to simplify organizational structure, to drive cost savings of $1.5B »

HPE President Antonio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

HPE

HP Enterprise

$14.70

0.09 (0.62%)

19:10
10/18/17
10/18
19:10
10/18/17
19:10
Earnings
HP Enterprise sees FY17 adjusted EPS view roughly $1.00, consensus $1.40 »

Sees FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

HPE

HP Enterprise

$14.70

0.09 (0.62%)

19:08
10/18/17
10/18
19:08
10/18/17
19:08
Earnings
HP Enterprise sees FY18 adjusted EPS $1.15-$1.25, consensus $1.20 »

HPE expects its non-GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

CME

CME Group

$136.37

0.18 (0.13%)

19:01
10/18/17
10/18
19:01
10/18/17
19:01
Hot Stocks
CME Group, JPX enter agremenet to launch TOPIX futures contract on CME »

CME Group and Japan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

  • 07

    Nov

UAL

United Continental

$67.99

0.48 (0.71%)

18:50
10/18/17
10/18
18:50
10/18/17
18:50
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CSX

CSX

$53.68

-0.55 (-1.01%)

18:49
10/18/17
10/18
18:49
10/18/17
18:49
Hot Stocks
CSX discloses reduction of locomotives in maintenance program »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 30

    Oct

VZ

Verizon

$48.65

0.25 (0.52%)

18:41
10/18/17
10/18
18:41
10/18/17
18:41
Periodicals
Verizon targets spring 2018 start of delayed online TV service, Bloomberg says »

Verizon is targeting a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

IBM

IBM

$159.53

12.99 (8.86%)

18:37
10/18/17
10/18
18:37
10/18/17
18:37
Hot Stocks
IBM CFO: Great start to 2H17 »

Says dollar is important…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 15

    Nov

SEAS

SeaWorld

$12.31

-0.17 (-1.36%)

18:26
10/18/17
10/18
18:26
10/18/17
18:26
Hot Stocks
SeaWorld to eliminate approximately 350 positions in restructuring program »

On October 18, SeaWorld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

JPM

JPMorgan

$97.99

0.37 (0.38%)

18:12
10/18/17
10/18
18:12
10/18/17
18:12
Hot Stocks
SEC names JPMorgan exec Redfearn Director of Division of Trading and Markets »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 02

    Nov

  • 05

    Nov

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

VZ

Verizon

$48.65

0.25 (0.52%)

18:10
10/18/17
10/18
18:10
10/18/17
18:10
Periodicals
Verizon targets spring start of delayed online TV service, Bloomberg says »

Verizon web TV…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

STLD

Steel Dynamics

$36.44

0.27 (0.75%)

18:04
10/18/17
10/18
18:04
10/18/17
18:04
Hot Stocks
Steel Dynamics CEO optimistic conditions in place to benefit FY18 consumption »

CEO Mark Millet said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CE

Celanese

$104.03

-0.24 (-0.23%)

18:03
10/18/17
10/18
18:03
10/18/17
18:03
Earnings
Celanese increases price for acetyls and engineered materials products »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLD

Steel Dynamics

$36.44

0.27 (0.75%)

18:01
10/18/17
10/18
18:01
10/18/17
18:01
Earnings
Steel Dynamics reports Q3 ex-items EPS 66c, consensus 66c »

Reports Q3 revenue $2.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

OPTT

Ocean Power

$2.00

0.56 (38.89%)

17:59
10/18/17
10/18
17:59
10/18/17
17:59
Syndicate
Ocean Power files to sell common stock in 'best efforts' offering »

No amount was provided.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

TOSBF

Toshiba, also use TOSYY

$3.02

-0.03 (-0.98%)

, TOSYY

Toshiba, also use TOSBF

$18.20

-0.11 (-0.60%)

17:58
10/18/17
10/18
17:58
10/18/17
17:58
Periodicals
Japan regulators probing Toshiba reporting practices for FY16/17, Nikkei says »

Japan's Securities…

TOSBF

Toshiba, also use TOSYY

$3.02

-0.03 (-0.98%)

TOSYY

Toshiba, also use TOSBF

$18.20

-0.11 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNW

Pinnacle West

$87.34

-0.42 (-0.48%)

17:53
10/18/17
10/18
17:53
10/18/17
17:53
Hot Stocks
Pinnacle West raises quarterly divided 6.1% to 69.5c per share »

Pinnacle West…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

  • 05

    Nov

  • 05

    Nov

  • 05

    Nov

GILD

Gilead

$80.01

-0.23 (-0.29%)

17:46
10/18/17
10/18
17:46
10/18/17
17:46
Hot Stocks
FDA grants regulatory approval to Kite's Yescarta »

Kite, a Gilead company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 26

    Oct

  • 06

    Nov

  • 12

    Feb

POT

Potash

$19.24

0.08 (0.42%)

, AGU

Agrium

$107.73

0.55 (0.51%)

17:37
10/18/17
10/18
17:37
10/18/17
17:37
Hot Stocks
Potash, Agrium: India approves proposed merger of equals transaction »

Potash Corporation of…

POT

Potash

$19.24

0.08 (0.42%)

AGU

Agrium

$107.73

0.55 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMI

Valmont

$160.85

1.9 (1.20%)

17:36
10/18/17
10/18
17:36
10/18/17
17:36
Earnings
Valmont lowers FY17 adjusted EPS view to $6.90-$7.04 from $7.06, consensus $7.09 »

Annual guidance was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.